bn:03509317n
Noun Concept
EL
Palivizumab
EN
Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus infections. Wikipedia
Relations
Sources